Join the DDA or

Abstral 200mcg recall

Risk of double dosing

July 30th 2020

Tagged: MHRA alert

By MHRA

Kyowa Kirin is recalling one batch of Abstral 200mcg sublingual tablets (fentanyl citrate) due to a packaging error.

The company has reported the possibility of double tablets in a single blister pocket, which creates the potential for double dosage.

The affected batch is:

Batch NumberExpiry DatePack SizeFirst Distributed
60877730231 July 20213024 Dec 2019

Healthcare professionals are asked to quarantine all remaining stock and return it to your supplier.

For stock control enquiries please contact: Stuart Hay, commercial director

For medical information enquiries please contact: